H-Gln(Mtt)-OH

H-Gln(Mtt)-OH is an N-protected glutamine derivative in which the side-chain amide of the glutamine backbone remains unmasked while the α-amino group is protected as an Mtt carbamate (2-(methylthio)trityl), forming a chiral amino acid intermediate with a free carboxylic acid. The molecule contains a stereogenic center at the α-carbon, a primary carboxylic acid for C-terminal activation, and a side-chain amide that can participate in hydrogen-bonding interactions and can be preserved through peptide coupling steps. The Mtt protecting group is designed for orthogonal deprotection relative to many common peptide protecting groups, enabling controlled exposure of the α-amine during protected amino acid synthesis and peptide assembly. The overall functionality profile supports peptide building block preparation, selective derivatization of the amino terminus, and downstream conversion into glutamine-containing peptide analogs and biochemical research intermediates.

1. Peptide Synthesis

H-Gln(Mtt)-OH is applied in peptide synthesis workflows where glutamine residues are required with a protected N-terminus and an activated C-terminus for amide bond formation. The free carboxylic acid enables standard peptide coupling chemistry, while the side-chain carboxamide is compatible with typical Fmoc/Boc-free or mixed protecting-group strategies that preserve glutamine integrity during chain elongation. The Mtt carbamate on the α-amino group supports stepwise peptide assembly by maintaining the N-terminus masked until a planned deprotection event. The resulting glutamine building block can be incorporated into linear peptides, branched constructs, and protected peptide fragments for subsequent purification and conversion into bioactive or screening libraries.

2. Protected Amino Acids

H-Gln(Mtt)-OH is used as a protected amino acid intermediate for N-protected glutamine chemistry, particularly when orthogonal deprotection control is needed across a multi-protecting-group sequence. The Mtt group provides a removable α-amino protection handle, while the carboxylic acid allows conversion to activated esters or coupling-ready derivatives as part of protected amino acid synthesis. The intact side-chain amide supports retention of glutamine's polar functionality, which can be important for maintaining solubility and for preserving hydrogen-bonding patterns in peptide scaffolds. The compound can therefore serve as a chiral starting material for generating glutamine-containing peptide building blocks, conformationally informative analogs, and protected fragments used in iterative synthesis.

3. Chemical Biology Probes

H-Gln(Mtt)-OH is suitable for chemical biology research requiring glutamine-bearing linkers, tags, or peptide handles that maintain amide-mediated recognition elements. The side-chain carboxamide can participate in specific hydrogen-bonding interactions and can be retained during conjugation sequences that modify other positions on a peptide or small molecule. The protected α-amino group and free carboxylic acid enable incorporation into peptide conjugates, affinity probes, and labeling scaffolds where controlled exposure of the amine supports sequential coupling to dyes, biotin-like handles, or reactive moieties. The Mtt-protected framework supports orthogonal deprotection logic, enabling staged assembly of probe molecules for biochemical interaction studies and molecular recognition mapping.

4. Peptidomimetics And SAR

H-Gln(Mtt)-OH is applied in peptidomimetic construction and structure-activity relationship studies where glutamine-like polarity and hydrogen-bonding capacity must be embedded into analogs. The α-amino protection strategy and free carboxyl group allow synthesis of glutamine-containing fragments that can be further transformed into constrained scaffolds, side-chain-modified analogs, or truncated peptide mimetics. The preserved side-chain amide can be used as a functional motif during scaffold diversification, including replacement with bioisosteres or conversion into derivatives that alter electronics while maintaining hydrogen-bonding geometry. The compound thus functions as a chiral intermediate for generating SAR-focused libraries and for supporting systematic variation of glutamine-dependent interactions in small peptide-like structures.

5. Pharmaceutical Intermediate Preparation

H-Gln(Mtt)-OH is relevant to pharmaceutical intermediate preparation where controlled glutamine incorporation into protected peptide intermediates supports downstream manufacturing of peptide-based drug candidates and processable intermediates. The carboxylic acid group provides a defined site for activation and coupling, while the Mtt-protected α-amine enables timed deprotection compatible with multi-step synthetic sequences that require selective exposure of reactive termini. The side-chain amide is maintained through coupling operations, supporting consistent handling of polar glutamine functionality during scale-up-oriented synthesis planning. The compound can be employed to produce glutamine-containing protected fragments, which can then be assembled into larger intermediates for purification, analytical characterization, and subsequent conversion into final peptide-related materials.

1. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

2. High fat diet and GLP-1 drugs induce pancreatic injury in mice

3. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

4. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

5. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment